Wefunder logo

InvVax

We use a new genetics platform to develop better vaccines for flu, COVID-19, etc

Last Funded April 2024

$124,203

raised from 132 investors

Highlights

1
Huge global market for these vaccines: Universal flu - $22B; COVID-19 - $5B
2
Chance to make an enormous societal impact
3
Patented durable and universal flu vaccine
4
Major smashes: Moderna, BioNTech, Novavax: Invest in the next one!

Featured Investor

Our Team

*To our knowledge, this is the only universal flu vaccine targeting invariant sequence of influenza, but there could be, in theory, others that we do not know about.

Source: Vision Research Reports.

To our knowledge, we are the only company focused on invariance. There could be others we do not know about.

Forward-looking projections are not guaranteed.

Forward-looking projections are not guaranteed.

Overview